Bring Moderna's Bob Langer to the court house, swear him in, and investigate and question, call Vanden Bossche, only he is to question mRNA technology and vaccine folk; if Bob did wrong, take every

by Paul Alexander

penny and more so, imprison him, if shown lives were lost due to the Moderna; all of them, get Bourla and Bancel too in the court house, separately...


‘For the third time this year, a surge in the share price of Cambridge, Massachusetts-based biotech outfit Moderna has minted a new billionaire. The latest newcomer to the three-comma-club is Robert Langer, a chemical engineering professor at MIT and a prolific scientist with more than 1,000 patents. His 3% stake in the company is now worth more than $1 billion.’

Moderna shares rose nearly 7% on Thursday, the day after the company announced it had collected enough data from phase three trials of its Covid-19 vaccine to submit to an independent board for analysis. The news came three days after Pfizer released positive results from trials of its own Covid-19 vaccine, developed with German biotech company BioNTech, which uses messenger RNA technology similar to that used by Moderna.

Forbes estimates that Langer is worth about $1.1 billion, with his fortune largely made up of his Moderna shares as well as smaller holdings in publicly traded biotech startups including Frequency Therapeutics, SQZ Biotechnologies and Lyra Therapeutics. He follows in the footsteps of Moderna CEO Stéphane Bancel, worth $2.7 billion, and fellow professor and biotech investor Timothy Springer, worth $1.5 billion, who passed the billion-dollar mark as Moderna’s stock price soared in April and May.

“I’ve been privileged to have engaged with Moderna since its earliest days,” Langer said in an emailed statement to Forbes. “I was initially inspired by the promise of messenger RNA as the potential basis for a transformative platform for new medicines and vaccines. The promise is definitely being realized.”’